MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
NGNE — Neurogene, Inc. Common Stock
NasdaqNeurogene, Inc. Common Stock
$25.45
-1.02(-3.85%)
- O
- 26.63
- H
- 26.74
- L
- 25.04
- V
- 120.81K
⏱️ End-of-day dataAs of Oct 6, 2026
NGNE — Latest News & Headlines
7 StoriesFive new hires’ options vest over four years, if they stay - Stock Titan
Five new hires’ options vest over four years, if they stay Stock Titan
$NGNE stock is down 9% today. Here's what we see in our data. - Quiver Quantitative
$NGNE stock is down 9% today. Here's what we see in our data. Quiver Quantitative
NGNE Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
NGNE Technical Analysis | Trend, Signals & Chart Patterns ChartMill
(NGNE) Risk Channels and Responsive Allocation - Stock Traders Daily
(NGNE) Risk Channels and Responsive Allocation Stock Traders Daily
A passive investor reports 2.23 million shares of Neurogene (NGNE). - Stock Titan
A passive investor reports 2.23 million shares of Neurogene (NGNE). Stock Titan
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) FinancialContent
Precision Trading with Neoleukin Therapeutics Inc. (NGNE) Risk Zones - Stock Traders Daily
Precision Trading with Neoleukin Therapeutics Inc. (NGNE) Risk Zones Stock Traders Daily